Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Pioneura Corporation has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being processed by 1 distinct examiner in 1 distinct art unit. The use of 1 distinct art unit indicates that the biotechnology claims are being evaluated within a specific examination group, which may provide a consistent technical baseline for the review.
HABTE, KAHSAY is the busiest examiner for the company, managing 1 pending office action. This single action represents the full extent of the company's current pending matters at the patent office. Because the portfolio is limited to 1 distinct examiner and 1 distinct art unit, the prosecution path is highly streamlined. Practitioners can focus their efforts on the specific examination style of HABTE, KAHSAY for this biotechnology filing.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HABTE, KAHSAY | 1 | 84.9% | +7.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18779948 | ACID ADDITION SALTS, COMPOSITIONS, AND METHODS OF TREATING THEREOF | HABTE, KAHSAY | — |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18779948 | ACID ADDITION SALTS, COMPOSITIONS, AND METHODS OF TREATING THEREOF | HABTE, KAHSAY | 1624 | §103Other | Non-Final OA | — | Pending | Jul 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPioneura Corporation has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Kahsay Habte has the most, with 1 of Pioneura Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.